Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 2003
Strong cytosine-guanosine-independent immunostimulation in humans and other primates by synthetic oligodeoxynucleotides with PyNTTTTGT motifsFernanda Elias, Juan Flo, Ricardo A Lopez, et al.
Neuroscience Letters|August 2, 2008
Oligonucleotide IMT504 reduces neuropathic pain after peripheral nerve injuryMaría Florencia Coronel, Andrés Hernando-Insúa, Juan Manuel Rodriguez, et al.
Molecular Neurobiology|December 8, 2023
Oligodeoxynucleotide IMT504: Effects on Central Nervous System Repair Following DemyelinationPatricia A Mathieu, Yim Rodriguez Sampertegui, Fernanda Elias, et al.
Vaccine|April 28, 2005
PyNTTTTGT prototype oligonucleotide IMT504 is a potent adjuvant for the recombinant hepatitis B vaccine that enhances the Th1 responseFernanda Elias, Juan Flo, Juan M Rodriguez, et al.
Vaccine|December 14, 2005
Ganglioside GM1-binding peptides as adjuvants of antigens inoculated by the intranasal routeAlejandro D Montaner, Analía De Nichilo, Fernanda Elias, et al.
Plos One|February 24, 2015
PyNTTTTGT and CpG immunostimulatory oligonucleotides: effect on granulocyte/monocyte colony-stimulating factor (GM-CSF) secretion by human CD56+ (NK and NKT) cellsJuan M Rodriguez, José Marchicio, Mariela López, et al.
Acta Cirurgica Brasileira|November 13, 2024
Results of the use of human platelet-rich fibrin membrane applied on colorrhaphy in nourished and malnourished ratsFábio Henrique de Oliveira, Lucas Silva de Oliveira, Luciana Xavier Pereira, et al.
Diseases of the Colon and Rectum|June 17, 2025
Partial Responders to Neoadjuvant Therapy and the Risk of Distant Metastases: Longer Intervals to Definitive Resection Is Not a Risk FactorLaura M Fernandez, Bruna Borba Vailati, Guilherme Pagin São Julião, et al.
Medicina|March 25, 2006
Oligonucleotide IMT504 induces an immunogenic phenotype and apoptosis in chronic lymphocytic leukemia cellsJuan M Rodriguez, Fernanda Elias, Alejandro Montaner, et al.
Glycobiology|November 9, 2023
Deglycosylated RBD produced in Pichia pastoris as a low-cost sera COVID-19 diagnosis tool and a vaccine candidateTommy Idrovo-Hidalgo, María F Pignataro, Luis M Bredeston, et al.
Pageof 1